SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-056505
Filing Date
2015-08-05
Accepted
2015-08-05 16:13:26
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-11815_110q.htm 10-Q 1163154
2 EX-31.1 a15-11815_1ex31d1.htm EX-31.1 10313
3 EX-31.2 a15-11815_1ex31d2.htm EX-31.2 10302
4 EX-32.1 a15-11815_1ex32d1.htm EX-32.1 5992
5 EX-32.2 a15-11815_1ex32d2.htm EX-32.2 5975
  Complete submission text file 0001104659-15-056505.txt   4961298

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vtae-20150630.xml EX-101.INS 933175
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtae-20150630.xsd EX-101.SCH 45100
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtae-20150630_cal.xml EX-101.CAL 49864
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vtae-20150630_lab.xml EX-101.LAB 429976
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtae-20150630_pre.xml EX-101.PRE 300048
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtae-20150630_def.xml EX-101.DEF 152502
Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Filer) CIK: 0001157602 (see all company filings)

IRS No.: 043567753 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36617 | Film No.: 151029131
SIC: 2834 Pharmaceutical Preparations